Literature DB >> 31327157

Activation of retinal Müller cells in response to glucose variability.

Fabiana Picconi1,2, Mariacristina Parravano3, Francesca Sciarretta4, Chiara Fulci4, Michela Nali4, Simona Frontoni5,6, Monica Varano3, Anna Maria Caccuri4,7.   

Abstract

PURPOSE: In the earliest stages of diabetic retinopathy (DR), a dysfunction of Müller cells, characterized by high levels of glial fibrillary acidic protein (GFAP), and aquaporins (AQP), has been observed. Although chronic hyperglycemia causes the activation of Müller cells, the effect of glycemic fluctuations is yet unknown. The aim of the study was to analyze the impact of glucose variability on rat retinal Müller cells (rMC-1) adapted to either normal (5 mM) or high (25 mM) glucose levels.
METHODS: rMC-1 were cultured in a medium containing either 5 mM (N cells) or 25 mM of glucose (H cells) and then incubated for 96 h in a medium containing (a) low glucose (either 1-3 or 5 mM), (b) basal glucose (either 5 or 25 mM), (c) high glucose (either 25 or 45 mM), (d) basal and high glucose alternated every 24 h; (e) low- and high glucose alternated every 24 h; (f) basal glucose with episodes of low glucose for 30 min twice a day. Müller cells activation was evaluated by measuring the levels of GFAP, AQP4, and phospho-active extracellular signal-regulated kinase (pERK).
RESULTS: Under both basal and high glucose concentrations rMC-1 were viable, but their response to glucose excursions was different. In N cells kept under normal (5 mM) glucose, a significant glial activation was measured not only in response to constant high glucose but also to alternating low/high glucose. In H cells, adapted to 25 mM glucose, a significant response was observed only after exposition to a lower (5 mM) glucose concentration.
CONCLUSION: Our results highlight Müller cells activation in response to glucose variability and a different susceptibility depending on the basal glucose conditions.

Entities:  

Keywords:  Glucose variability; Müller cells activation; Retinal neurodegeneration

Mesh:

Substances:

Year:  2019        PMID: 31327157     DOI: 10.1007/s12020-019-02017-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  34 in total

1.  The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy.

Authors:  Lakshminarayanan Varadhan; Tracy Humphreys; Adrian B Walker; George I Varughese
Journal:  Diabetes Res Clin Pract       Date:  2014-01-06       Impact factor: 5.602

2.  Retinal ganglion cell neuronal damage in diabetes and diabetic retinopathy.

Authors:  Dorothy Sk Ng; Peggy Pc Chiang; Gavin Tan; Cm Gemmy Cheung; Ching-Yu Cheng; Carol Y Cheung; Tien Y Wong; Ecosse L Lamoureux; Mohammad K Ikram
Journal:  Clin Exp Ophthalmol       Date:  2016-03-23       Impact factor: 4.207

3.  Establishment and characterization of a retinal Müller cell line.

Authors:  V P Sarthy; S J Brodjian; K Dutt; B N Kennedy; R P French; J W Crabb
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-01       Impact factor: 4.799

4.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.

Authors:  Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Lucia Martinelli; Enrico Motz; Antonio Ceriello
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

5.  Altered retinal metabolism in diabetes. I. Microanalysis of lipid, glucose, sorbitol, and myo-inositol in the choroid and in the individual layers of the rabbit retina.

Authors:  L C MacGregor; L R Rosecan; A M Laties; F M Matschinsky
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

6.  Neuroprotection by rat Müller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation.

Authors:  Andrea Matteucci; Lucia Gaddini; Marika Villa; Monica Varano; Mariacristina Parravano; Valentina Monteleone; Francesca Cavallo; Lanfranco Leo; Cinzia Mallozzi; Fiorella Malchiodi-Albedi; Flavia Pricci
Journal:  Exp Eye Res       Date:  2014-05-28       Impact factor: 3.467

7.  Reactive oxygen species regulate prosurvival ERK1/2 signaling and bFGF expression in gliosis within the retina.

Authors:  Gillian Groeger; Francesca Doonan; Thomas G Cotter; Maryanne Donovan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-25       Impact factor: 4.799

8.  Regulation of autophagy by glucose in Mammalian cells.

Authors:  Félix Moruno; Eva Pérez-Jiménez; Erwin Knecht
Journal:  Cells       Date:  2012-07-27       Impact factor: 6.600

9.  Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability.

Authors:  Fabiana Picconi; Mariacristina Parravano; Dorina Ylli; Patrizio Pasqualetti; Sara Coluzzi; Ilaria Giordani; Ilaria Malandrucco; Davide Lauro; Fabio Scarinci; Paola Giorno; Monica Varano; Simona Frontoni
Journal:  Acta Diabetol       Date:  2017-02-25       Impact factor: 4.280

10.  The effects of high glucose condition on rat tenocytes in vitro and rat Achilles tendon in vivo.

Authors:  Y Ueda; A Inui; Y Mifune; R Sakata; T Muto; Y Harada; F Takase; T Kataoka; T Kokubu; R Kuroda
Journal:  Bone Joint Res       Date:  2018-06-05       Impact factor: 5.853

View more
  16 in total

1.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

2.  Genotypic variability in radial resistance to water flow in olive roots and its response to temperature variations.

Authors:  Á López-Bernal; O García-Tejera; L Testi; F J Villalobos
Journal:  Tree Physiol       Date:  2020-04-08       Impact factor: 4.196

3.  A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose.

Authors:  Diego Sbardella; Grazia Raffaella Tundo; Alice Mecchia; Camilla Palumbo; Maria Grazia Atzori; Lauretta Levati; Alessandra Boccaccini; Anna Maria Caccuri; Paolo Cascio; Pedro Miguel Lacal; Grazia Graziani; Monica Varano; Massimiliano Coletta; Mariacristina Parravano
Journal:  Cell Biosci       Date:  2022-07-16       Impact factor: 9.584

4.  Effects of thiamine and fenofibrate on high glucose and hypoxia-induced damage in cell models of the inner blood-retinal barrier.

Authors:  Aurora Mazzeo; Chiara Gai; Marina Trento; Massimo Porta; Elena Beltramo
Journal:  Acta Diabetol       Date:  2020-07-12       Impact factor: 4.280

Review 5.  The innate immune system in diabetic retinopathy.

Authors:  Warren W Pan; Feng Lin; Patrice E Fort
Journal:  Prog Retin Eye Res       Date:  2021-01-08       Impact factor: 19.704

6.  LRP1 mediates the IGF-1-induced GLUT1 expression on the cell surface and glucose uptake in Müller glial cells.

Authors:  Virginia Actis Dato; María Cecilia Sánchez; Gustavo Alberto Chiabrando
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.379

Review 7.  Recent Developments in Diabetic Retinal Neurodegeneration: A Literature Review.

Authors:  Shani Pillar; Elad Moisseiev; Jelizaveta Sokolovska; Andrzej Grzybowski
Journal:  J Diabetes Res       Date:  2020-12-07       Impact factor: 4.011

8.  YAP is essential for TGF-β-induced retinal fibrosis in diabetic rats via promoting the fibrogenic activity of Müller cells.

Authors:  Wei Zhang; Yichun Kong
Journal:  J Cell Mol Med       Date:  2020-09-20       Impact factor: 5.310

9.  Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes.

Authors:  Fabio Scarinci; Fabiana Picconi; Gianni Virgili; Monica Varano; Paola Giorno; Simona Frontoni; Mariacristina Parravano
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

Review 10.  Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review.

Authors:  Xiaochun Zhang; Xue Yang; Bao Sun; Chunsheng Zhu
Journal:  Commun Biol       Date:  2021-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.